Arrowstreet Capital Limited Partnership Has $4.21 Million Stock Holdings in Varex Imaging Co. (NASDAQ:VREX)

Arrowstreet Capital Limited Partnership boosted its holdings in Varex Imaging Co. (NASDAQ:VREX) by 2,223.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 288,630 shares of the company’s stock after buying an additional 276,207 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 0.70% of Varex Imaging worth $4,211,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. FMR LLC grew its holdings in shares of Varex Imaging by 4,739.2% during the third quarter. FMR LLC now owns 200,341 shares of the company’s stock worth $2,388,000 after purchasing an additional 196,201 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of Varex Imaging by 1,359.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 52,295 shares of the company’s stock worth $623,000 after buying an additional 48,713 shares in the last quarter. Walleye Capital LLC acquired a new stake in Varex Imaging in the third quarter worth $229,000. Point72 Asset Management L.P. acquired a new stake in shares of Varex Imaging in the 3rd quarter valued at about $415,000. Finally, Wellington Management Group LLP acquired a new stake in Varex Imaging in the 3rd quarter valued at $19,801,000.

Insider Buying and Selling

In related news, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total transaction of $98,338.76. Following the completion of the sale, the chief executive officer now directly owns 190,193 shares in the company, valued at $2,137,769.32. This represents a 4.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Kimberley E. Honeysett sold 4,007 shares of the firm’s stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total transaction of $51,329.67. Following the completion of the transaction, the senior vice president now owns 4,002 shares in the company, valued at $51,265.62. This represents a 50.03 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Oppenheimer cut their target price on Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a research report on Friday, February 7th. B. Riley reaffirmed a “buy” rating and set a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th. Finally, StockNews.com upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Friday, February 7th.

Varex Imaging Stock Down 0.8 %

VREX opened at $7.46 on Wednesday. The firm has a market capitalization of $307.35 million, a P/E ratio of -6.38 and a beta of 0.65. Varex Imaging Co. has a one year low of $7.33 and a one year high of $18.17. The company has a fifty day moving average price of $12.43 and a 200-day moving average price of $13.35. The company has a debt-to-equity ratio of 1.02, a current ratio of 4.36 and a quick ratio of 2.50.

Varex Imaging (NASDAQ:VREX) last announced its earnings results on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. Equities research analysts expect that Varex Imaging Co. will post 0.53 earnings per share for the current fiscal year.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.